dacarbazine and Fibrous Tissue Neoplasms

dacarbazine has been researched along with Fibrous Tissue Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al-Muderis, O; Constantinidou, A; Fisher, C; Jones, RL; Judson, I; Olmos, D; Thway, K	1

Other Studies

1 other study(ies) available for dacarbazine and Fibrous Tissue Neoplasms

Article	Year
Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour. Acta oncologica (Stockholm, Sweden), 2012, Volume: 51, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Dacarbazine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Neoplasms, Fibrous Tissue; Prognosis; Retrospective Studies; Survival Rate	2012

Article

Year

Conventional anthracycline-based chemotherapy has limited efficacy in solitary fibrous tumour.

Acta oncologica (Stockholm, Sweden), 2012, Volume: 51, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Anthracyclines; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Dacarbazine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Staging; Neoplasms, Fibrous Tissue; Prognosis; Retrospective Studies; Survival Rate

2012